Multidisciplinary Collaboration for the Optimization of Antibiotic Prescription: Analysis of Clinical Cases of Pneumonia between Emergency, Internal Medicine, and Pharmacy Services - PubMed

Background: Pneumonia is a lung parenchyma acute infection usually treated with antibiotics. Increasing bacterial resistances force the review and control of antibiotic use criteria in different health departments.

Objective: Evaluate the adequacy of antibiotic treatment in community-acquired pneumonia in patients initially attended at the emergency department and then admitted to the internal medicine service of the Alto Deba Hospital-Osakidetza Basque Country Health Service (Spain).

Methods: Observational, retrospective study, based on the review of medical records of patients with community-acquired pneumonia attended at the hospital between January and May 2021. The review was made considering the following items: antimicrobial treatment indication, choice of antibiotic, time of administration of the first dose, adequacy of the de-escalation-sequential therapy, duration of treatment, monitoring of efficacy and adverse effects, and registry in the medical records. The review was made by the research team (professionals from the emergency department, internal medicine, and pharmacy services).

Results: Fifty-five medical records were reviewed. The adequacy of the treatments showed that antibiotic indication, time of administration of the first dose, and monitoring of efficacy and adverse effects were the items with the greatest agreement between the three departments. This was not the case with the choice of antibiotic, de-escalation/sequential therapy, duration of treatment, and registration in the medical record, which have been widely discussed. The choice of antibiotic was optimal in 63.64% and might have been better in 25.45%. De-escalation/oral sequencing might have been better in 50.91%. The treatment duration was optimal in 45.45% of the patients and excessive in 45.45%.

Discussion: The team agreed to disseminate these data among the hospital professionals and to propose audits and feedback through an antibiotic stewardship program. Besides this, implementing the local guideline and defining stability criteria to apply sequential therapy/de-escalation was considered essential.

1. 1. Metlay J.P., Waterer G.W., Long A.C., Anzueto A., Brozek J., Crothers K., Cooley L.A., Dean N.C., Fine M.J., Flanders S.A., et al. Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir. Crit. Care Med. 2019;200:e45–e67. doi: 10.1164/rccm.201908-1581ST. - DOI - PMC - PubMed
2. 1. Jahanihashemi H., Babaie M., Bijani S., Bazzazan M., Bijani B. Poverty as an Independent Risk Factor for In-Hospital Mortality in Community-Acquired Pneumonia: A Study in a Developing Country Population. Int. J. Clin. Pract. 2018;72:e13085. doi: 10.1111/ijcp.13085. - DOI - PubMed
3. 1. Millett E.R.C., Quint J.K., Smeeth L., Daniel R.M., Thomas S.L. Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study. PLoS ONE. 2013;8:e75131. doi: 10.1371/journal.pone.0075131. - DOI - PMC - PubMed
4. 1. Partouche H., Lepoutre A., du Vaure C.B., Poisson T., Toubiana L., Gilberg S. Incidence of All-Cause Adult Community-Acquired Pneumonia in Primary Care Settings in France. Med. Mal. Infect. 2018;48:389–395. doi: 10.1016/j.medmal.2018.02.012. - DOI - PubMed
5. 1. Bjarnason A., Westin J., Lindh M., Andersson L.-M., Kristinsson K.G., Löve A., Baldursson O., Gottfredsson M. Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study. Open Forum Infect. Dis. 2018;5:ofy010. doi: 10.1093/ofid/ofy010. - DOI - PMC - PubMed